Franklin Resources’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Franklin Resources’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15,055	Closed	-$45K	–	1558
2018 Q3	$45K	Sell	15,055 -2,706	-15%	-$9.58K	﹤0.01%	1510
2018 Q2	$65K	Sell	17,761 -690	-4%	-$2.77K	﹤0.01%	1459
2018 Q1	$65K	Buy	18,451 +2,370	+15%	+$10K	﹤0.01%	1495
2017 Q4	$50K	Buy	16,081 +1,254	+8%	+$6.03K	﹤0.01%	1499
2017 Q3	$104K	Buy	14,827 +2,029	+16%	+$16.3K	﹤0.01%	1469
2017 Q2	$118K	Buy	12,798 +511	+4%	+$4.92K	﹤0.01%	1484
2017 Q1	$132K	Buy	+12,287	New	+$126K	﹤0.01%	1475

Other funds holding NVLN

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's NVLN Position: Q4 2018 in Review

Franklin Resources sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2018, closing a stake of 15,055 shares — an estimated $45K sold.

Franklin Resources first reported a position in NVLN in Q1 2017 and held it in 7 quarters. The position peaked at $132K in Q1 2017. 36 funds tracked by Wall St. Rank hold NVLN as of Q4 2018.

Franklin Resources reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2018 after selling out during the quarter.
Franklin Resources sold 15,055 Novelion Therapeutics Inc. Common Shares shares in Q4 2018, an estimated $45K.
Franklin Resources first reported a position in Novelion Therapeutics Inc. Common Shares in Q1 2017 and held it in 7 quarters.
Franklin Resources's Novelion Therapeutics Inc. Common Shares position peaked at $132K in Q1 2017.
36 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2018.

Based on Franklin Resources's 13F filing for Q4 2018, filed 12 Feb 2019.